Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene.
about
Vaccinia virus 4c (A26L) protein on intracellular mature virus binds to the extracellular cellular matrix lamininPoxvirus cell entry: how many proteins does it take?Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycansStructural and Biochemical Characterization of the Vaccinia Virus Envelope Protein D8 and Its Recognition by the Antibody LA5Drosophila S2 cells are non-permissive for vaccinia virus DNA replication following entry via low pH-dependent endocytosis and early transcriptionPox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins.New classes of orthopoxvirus vaccine candidates by functionally screening a synthetic library for protective antigens.The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 proteinThe membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell componentsPoxvirus multiprotein entry-fusion complexThe myristate moiety and amino terminus of vaccinia virus l1 constitute a bipartite functional region needed for entryInteraction between the G3 and L5 proteins of the vaccinia virus entry-fusion complex.Smallpox vaccines: targets of protective immunity.The envelope G3L protein is essential for entry of vaccinia virus into host cellsVaccinia virus entry into cells via a low-pH-dependent endosomal pathway.Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein.Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex.Lipid membranes in poxvirus replication.Transcriptional repression and RNA silencing act synergistically to demonstrate the function of the eleventh component of the vaccinia virus entry-fusion complex.Sequence-divergent chordopoxvirus homologs of the o3 protein maintain functional interactions with components of the vaccinia virus entry-fusion complex.Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pHCharacterization of the VP39 envelope protein from Singapore grouper iridovirus.Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex.Two distinct low-pH steps promote entry of vaccinia virus.Resistance of a vaccinia virus A34R deletion mutant to spontaneous rupture of the outer membrane of progeny virions on the surface of infected cellsOrthopoxvirus species and strain differences in cell entry.Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.Vaccinia virus E2L null mutants exhibit a major reduction in extracellular virion formation and virus spread.Analysis of viral membranes formed in cells infected by a vaccinia virus L2-deletion mutant suggests their origin from the endoplasmic reticulum.Role of the vaccinia virus O3 protein in cell entry can be fulfilled by its Sequence flexible transmembrane domain.Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex.A conserved sequence within the H2 subunit of the vaccinia virus entry/fusion complex is important for interaction with the A28 subunit and infectivity.Vaccinia virus l1 protein is required for cell entry and membrane fusion.Vaccinia virus entry/fusion complex subunit A28 is a target of neutralizing and protective antibodiesExpression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion.Orthopoxvirus targets for the development of new antiviral agents.Vaccinia virus strain differences in cell attachment and entry.Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry.Characterization of an envelope gene VP19 from Singapore grouper iridovirus.Characterization of a newly identified 35-amino-acid component of the vaccinia virus entry/fusion complex conserved in all chordopoxviruses.
P2860
Q24336532-E2F362CE-3680-4416-AF30-04108B7E5958Q27002455-818FE422-7037-4C08-98EC-D744404231B7Q27488704-25A101C6-1899-4860-AB6A-D9016229F471Q27679281-E020F6B9-E622-47C2-91B1-6B516429C76DQ28477161-7DBAE8E4-959D-4F3C-B8F4-FBC8B8587CC7Q30809790-425BF9DA-C907-422F-B094-84D13DE87B49Q33508318-6485E85C-29B3-4E88-A152-E5B435540124Q34039477-B873D2DE-979E-4B8D-B088-931A8D501AF0Q34109783-049D4EF6-B467-445A-A589-24A50B50E74AQ34202362-11CE4A64-D33B-4EF8-B85E-AA3966A66CEDQ34259469-3FCF5392-50A8-44CD-BF8B-7FDB3C5BD0DAQ34778139-BBA6B7F8-C073-49BC-B9C5-543E81131C00Q34780607-1EE7D4DF-3597-48FB-B419-2DCC7A035396Q35024119-C20F0096-4A9F-40DD-ACCA-BB847417F107Q35024254-E440AA8D-E301-45C0-95DD-54B1C55D941CQ35101363-E22875B7-4D90-4094-92B2-1B77FD7CB644Q35101454-B79498C4-7CA8-4F8A-874A-04D1E2EC12EEQ35260919-2B2014BA-D1C7-4411-963C-90F428FE27F4Q35665944-77E071F2-9A75-40D0-A734-F0075AC18DF1Q35689728-08A3F031-2FD4-485F-B594-E31A8E0ACB8CQ35826881-8EF4CD92-05A9-48E0-9FC9-538DC268FED8Q35829196-FC8BE245-04A4-45A3-AA74-5445CCA893D6Q35857238-0DF06841-8F73-4344-A569-2789A7C9F3AFQ35947676-9F03528A-89CB-40EE-B43D-B8FB3FCA342FQ36103310-1CF9335E-32EA-4B3D-9EB5-9DC8C668FBAEQ36315941-00AC1A92-C82A-4FA3-B276-BFA8CCDE529AQ36498147-221B8985-F904-442B-AFA8-C6C8DB99AB21Q36540095-15C040EA-6F6F-4EC0-A9B4-D14F99419F32Q36559826-65A8850E-B168-4FB9-B00D-51B0299C00B6Q36655196-94A032FD-527A-4256-87CD-349BB41501D3Q36673363-22A5EF8F-AA5E-421E-B2AF-A9274011C8C7Q36747975-050C7190-8E7D-48C1-B387-7B2506FB8359Q36845831-8FD1E30F-A8BB-4246-9A2D-5AF816F8DEBCQ37066691-64F90883-4E7C-4990-8E58-DE03CB441178Q37099872-2767C1DC-2E02-430A-B1F5-3D875BA556F6Q37173398-0C92E357-B71C-4970-82F3-427063B7EC75Q37238558-14BDFB85-BEFA-4A1C-B11F-D53FAD29D5DDQ37359610-A6647EF6-8DFE-48AE-B407-ED5AD4F696B1Q37426781-6C1BA572-B331-4D39-950A-8290B68B9D0AQ37452527-906E37A7-44C7-4867-8275-15F6B2A41172
P2860
Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Entry of vaccinia virus and ce ...... tein encoded by the A16L gene.
@ast
Entry of vaccinia virus and ce ...... tein encoded by the A16L gene.
@en
Entry of vaccinia virus and ce ...... tein encoded by the A16L gene.
@nl
type
label
Entry of vaccinia virus and ce ...... tein encoded by the A16L gene.
@ast
Entry of vaccinia virus and ce ...... tein encoded by the A16L gene.
@en
Entry of vaccinia virus and ce ...... tein encoded by the A16L gene.
@nl
prefLabel
Entry of vaccinia virus and ce ...... tein encoded by the A16L gene.
@ast
Entry of vaccinia virus and ce ...... tein encoded by the A16L gene.
@en
Entry of vaccinia virus and ce ...... tein encoded by the A16L gene.
@nl
P2860
P1433
P1476
Entry of vaccinia virus and ce ...... tein encoded by the A16L gene.
@en
P2093
Suany Ojeda
Tatiana G Senkevich
P2860
P356
10.1128/JVI.80.1.51-61.2006
P407
P50
P577
2006-01-01T00:00:00Z